Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
drug
![US doctor groups debate best use of new weight-loss drugs By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/US-doctor-groups-debate-best-use-of-new-weight-loss-drugs-400x400.jpg)
Lilly to buy Versanis for up to $1.93 billion to boost obesity drug portfolio By Reuters
- By nasdaqpicks.com
- . 14 July 2023
© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File
![Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Roivant-in-Talks-to-Sell-Stomach-Drug-to-Roche-in-400x400.jpeg)
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
- By nasdaqpicks.com
- . 14 July 2023
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
![Stop insuring carbon projects 'immediately', NGOs tell CEOs By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/Stop-insuring-carbon-projects-immediately-NGOs-tell-CEOs-By-Reuters-400x400.jpg)
Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal
- By nasdaqpicks.com
- . 14 July 2023
© Reuters. FILE PHOTO: A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer/File Photo (Reuters) – Biotech company Roivant
![Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Roivant-in-Talks-to-Sell-Stomach-Drug-to-Roche-in-400x400.jpeg)
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
- By nasdaqpicks.com
- . 13 July 2023
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
![Sex, Drugs and Spreadsheets: Dr. Glazer Treats Wall Street's Addiction Surge](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Sex-Drugs-and-Spreadsheets-Dr-Glazer-Treats-Wall-Street039s-Addiction-400x400.jpeg)
Sex, Drugs and Spreadsheets: Dr. Glazer Treats Wall Street's Addiction Surge
- By nasdaqpicks.com
- . 11 July 2023
Demand has exploded for Dr. Glazer’s practice, which treats traders, fund managers and bankers who battle mental-health problems. Source link
![In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/In-Battle-With-Microsoft-Google-Bets-on-Medical-AI-Program-400x400.jpeg)
In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry
- By nasdaqpicks.com
- . 8 July 2023
The search giant is fine-tuning chatbot technology via medical licensing exams. Source link
![Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Factbox-Companies-in-Alzheimers-race-after-US-nod-for-EisaiBiogen-drug-400x400.jpg)
Factbox-Companies in Alzheimer’s race after US nod for Eisai/Biogen drug By Reuters
- By nasdaqpicks.com
- . 7 July 2023
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
![Biogen stock whipsaws despite FDA granting full approval for Alzheimer](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Biogen-stock-whipsaws-despite-FDA-granting-full-approval-for-Alzheimers-400x400.jpg)
Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com
- By nasdaqpicks.com
- . 7 July 2023
© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi
![US FDA grants standard approval of Eisai/Biogen Alzheimer's drug By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/US-FDA-grants-standard-approval-of-EisaiBiogen-Alzheimers-drug-By-400x400.jpg)
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
- By nasdaqpicks.com
- . 7 July 2023
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
![FDA Forces the Only Drug for Preterm Births to Leave Market](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/FDA-Forces-the-Only-Drug-for-Preterm-Births-to-Leave-400x400.jpeg)
FDA Forces the Only Drug for Preterm Births to Leave Market
- By nasdaqpicks.com
- . 6 April 2023
Health Makena injections for pregnant women with previous early births are ineffective, agency says Source link